当前位置:首页 - 行情中心 - 海昇药业(870656) - 财务分析

海昇药业

(870656)

  

流通市值:2.46亿  总市值:12.32亿
流通股本:1600.01万   总股本:8000.00万

海昇药业(870656)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润0.17亿元,每股收益0.21元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益65780.83万元,未分配利润19780.90万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产67684.64万元,负债1903.81万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入41,910,557.19215,101,819.65165,979,586.54126,708,771.81
营业总成本22,625,437.43117,244,548.2589,073,883.4963,077,102.6
营业利润19,396,093.5398,438,920.0277,645,770.5962,835,042.09
利润总额19,400,698.5398,496,651.4877,647,493.9962,835,042.09
净利润16,766,047.6584,755,693.8466,783,324.353,965,557.28
其他综合收益----
综合收益总额16,766,047.6584,755,693.8466,783,324.353,965,557.28
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计529,409,707.17178,234,543.26174,176,262.35176,243,160.86
非流动资产合计147,436,686.95129,140,723.97117,517,917.96100,045,957.62
资产总计676,846,394.12307,375,267.23291,694,180.31276,289,118.48
流动负债合计18,453,933.6922,320,730.224,947,925.0322,696,542.43
非流动负债合计584,168.76661,692.4739,216.05816,739.68
负债合计19,038,102.4522,982,422.625,687,141.0823,513,282.11
归属于母公司股东权益合计657,808,291.67284,392,844.63266,007,039.23252,775,836.37
股东权益合计657,808,291.67284,392,844.63266,007,039.23252,775,836.37
负债和股东权益合计676,846,394.12307,375,267.23291,694,180.31276,289,118.48
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计32,511,620164,883,844.79136,450,839.894,635,001.93
经营活动现金流出小计28,083,657.07105,002,423.1579,438,614.0856,153,392.72
经营活动产生的现金流量净额4,427,962.9359,881,421.6557,012,225.7238,481,609.21
投资活动现金流入小计----
投资活动现金流出小计10,322,508.3328,069,156.3223,423,384.5612,597,873.59
投资活动产生的现金流量净额-10,322,508.33-28,069,156.32-23,423,384.56-12,597,873.59
筹资活动现金流入小计367,150,000---
筹资活动现金流出小计8,171,60074,338,460.4473,282,444.4472,964,444.44
筹资活动产生的现金流量净额358,978,400-74,338,460.44-73,282,444.44-72,964,444.44
汇率变动对现金及现金等价物的影响240,089.751,871,260.992,097,871.52,051,322.31
现金及现金等价物净增加额353,323,944.35-40,654,934.12-37,595,731.78-45,029,386.51
期末现金及现金等价物余额454,706,743.5199,090,299.41102,149,501.7594,715,847.02
TOP↑